LLY compared with ABT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ABTAbbott Laboratories

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ABTAbbott Laboratories

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ABT

3 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 21 '26±5.3%▼−1.89%×0.36

Q2 FY26±4.3%▲+10.71%×2.49

= impliedLLY realized, solidABT realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±4.4%

▼−6.00%

×1.36

Jan 22 '26±3.2%▼−10.04%×3.13

LLYELI Lilly & Co

1,431.79▲+1.47%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ABTAbbott Laboratories

109.56▼−0.55%

Regular sessionNov 3 '26

Mkt cap$183.8BRevenue$12.6BQ2 FY26Revenue$44.3BFY25

Compare

Regular sessionNov 3 '26

LLYELI Lilly & Co

ABTAbbott Laboratories

1,431.79▲+1.47%

Price

109.56▼−0.55%

$1.3T

Mkt cap

$183.8B

Q3 FY26$24.4B

Revenue

$12.6BQ2 FY26

FY25$65.2B

Revenue

$44.3BFY25

LLY1,431.79▲+1.47%vsABT109.56▼−0.55%Regular sessionNov 3 '26